CD248 and rheumatoid arthritis: Pathogenic activated fibroblasts have previously been identified in RA, these were characterised by increased expression of podoplanin (PDPN), CD106 (VCAM-1) and CD248 (tumour endothelial marker-1/endosialin) [13].